Kristine Vb Ahern, MD
Dermatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahern’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A69488 · Current
Licensed to practise in California · since 1999 · expires 2027-06-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$180,894
Medicare paid this office $180,894 for 475 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 337 | $33,965 | $71 |
| Return visit (30+ min) | 241 | $32,954 | $108 |
| Destruction of skin growth, 1-14 growths | 130 | $17,762 | $108 |
| Destruction of precancer skin growth, 1 growth | 243 | $17,289 | $51 |
| Biopsy of related skin growth, first growth | 128 | $11,533 | $81 |
See all 11 services
| Short return visit (20+ min) | 337 | $33,965 | $71 |
| Return visit (30+ min) | 241 | $32,954 | $108 |
| Destruction of skin growth, 1-14 growths | 130 | $17,762 | $108 |
| Destruction of precancer skin growth, 1 growth | 243 | $17,289 | $51 |
| Biopsy of related skin growth, first growth | 128 | $11,533 | $81 |
| Destruction of precancer skin growth, 2-14 growths | 181 | $5,816 | $7 |
| Punch biopsy, first skin growth | 26 | $3,056 | $118 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 18 | $2,342 | $117 |
| Biopsy of related skin growth, each additional growth | 31 | $2,043 | $50 |
| Short return visit | 20 | $1,067 | $51 |
| New patient visit (30+ min) | 12 | $926 | $77 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 649 | More than 89% of doctors who do this |
| Removal or shaving of skin growth | 32 | More than 75% of doctors who do this |
| Skin biopsy | 157 | More than 82% of doctors who do this |
Who their Medicare patients are
475 Original Medicare patients in 2024. Average age 76 · Women 57% · Also on Medicaid 3% · Health risk score 0.77. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 56% · Coronary heart disease 17% · Cancer 15% · Chronic kidney disease 14% · Atrial fibrillation 14% · Diabetes 13% · Depression 8% · Heart failure 7% · COPD 6% · Stroke 4% · Dementia 2%.
The office billed $702,831, Medicare allowed $252,543 and paid $180,894; for 3,031 services of 54 kinds; $2,165 of it was for drugs given in the office and $178,729 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 475 | 3,031 | 76 | 0.77 | $702,831 | $180,894 |
| 2023 | 491 | 2,541 | 76 | 0.78 | $474,930 | $137,031 |
| 2022 | 494 | 2,799 | 76 | 0.79 | $468,819 | $136,849 |
| 2021 | 402 | 2,179 | 76 | 0.77 | $416,149 | $125,114 |
| 2020 | 349 | 1,601 | 75 | 0.88 | $295,224 | $81,405 |
| 2019 | 369 | 1,642 | 74 | 0.77 | $339,557 | $92,408 |
| 2018 | 375 | 1,707 | 75 | 0.85 | $356,364 | $96,125 |
| 2017 | 335 | 1,732 | 75 | 0.83 | $335,128 | $95,848 |
| 2016 | 331 | 1,761 | 74 | 0.84 | $406,007 | $109,497 |
| 2015 | 309 | 1,551 | 75 | 0.82 | $368,422 | $105,035 |
| 2014 | 307 | 1,665 | 74 | 0.91 | $303,103 | $88,942 |
| 2013 | 273 | 1,492 | 74 | 0.81 | $278,588 | $79,230 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 335 | $33,342 | $72 |
| Return visit (30+ min) | 187 | $23,406 | $107 |
| Destruction of skin growth, 1-14 growths | 122 | $16,807 | $115 |
| Biopsy of related skin growth, first growth | 134 | $14,387 | $93 |
| Destruction of precancer skin growth, 1 growth | 213 | $13,223 | $48 |
| Destruction of precancer skin growth, 2-14 growths | 164 | $5,397 | $7 |
| Biopsy of related skin growth, each additional growth | 39 | $2,812 | $49 |
| Punch biopsy, first skin growth | 19 | $2,415 | $127 |
| Application of ultraviolet light to skin | 28 | $2,173 | $25 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 16 | $1,948 | $115 |
| New patient visit (30+ min) | 22 | $1,655 | $75 |
| Short return visit | 21 | $986 | $45 |
2022: 13 services
| Short return visit (20+ min) | 279 | $27,310 | $73 |
| Return visit (30+ min) | 176 | $22,337 | $107 |
| Destruction of precancer skin growth, 1 growth | 217 | $13,374 | $50 |
| Destruction of skin growth, 1-14 growths | 104 | $13,182 | $110 |
| Biopsy of related skin growth, first growth | 118 | $12,698 | $98 |
| Application of ultraviolet light to skin | 26 | $7,673 | $24 |
| Destruction of precancer skin growth, 2-14 growths | 166 | $5,911 | $7 |
| New patient visit (45+ min) | 34 | $4,696 | $138 |
| Biopsy of related skin growth, each additional growth | 47 | $3,491 | $54 |
| New patient visit (30+ min) | 38 | $3,198 | $84 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $2,956 | $156 |
| Punch biopsy, first skin growth | 21 | $2,782 | $126 |
| Short return visit | 17 | $785 | $46 |
2021: 14 services
| Short return visit (20+ min) | 232 | $24,639 | $76 |
| Return visit (30+ min) | 149 | $18,059 | $102 |
| Destruction of skin growth, 1-14 growths | 91 | $11,301 | $110 |
| Biopsy of related skin growth, first growth | 101 | $10,714 | $97 |
| Application of ultraviolet light to skin | 13 | $10,227 | $25 |
| Destruction of precancer skin growth, 1 growth | 164 | $9,841 | $49 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $4,293 | $172 |
| Destruction of precancer skin growth, 2-14 growths | 118 | $3,771 | $7 |
| New patient visit (45+ min) | 26 | $3,736 | $144 |
| New patient visit (30+ min) | 42 | $3,655 | $87 |
| Punch biopsy, first skin growth | 19 | $2,799 | $140 |
| Biopsy of related skin growth, each additional growth | 34 | $2,744 | $55 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 14 | $1,694 | $113 |
| Short return visit | 16 | $756 | $44 |
2020: 11 services
| Return visit (30+ min) | 182 | $18,046 | $82 |
| Short return visit (20+ min) | 163 | $12,946 | $64 |
| Destruction of skin growth, 1-14 growths | 76 | $8,803 | $107 |
| Application of ultraviolet light to skin | 19 | $7,618 | $24 |
| Biopsy of related skin growth, first growth | 69 | $7,568 | $97 |
| Destruction of precancer skin growth, 1 growth | 122 | $6,723 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 83 | $2,309 | $6 |
| Biopsy of related skin growth, each additional growth | 25 | $2,230 | $52 |
| New patient visit (30+ min) | 16 | $1,060 | $66 |
| New patient visit (15+ min) | 14 | $847 | $61 |
| Short return visit | 20 | $759 | $36 |
2019: 12 services
| Return visit (30+ min) | 170 | $18,562 | $89 |
| Short return visit (20+ min) | 186 | $13,997 | $60 |
| Destruction of skin growth, 1-14 growths | 84 | $9,383 | $102 |
| Destruction of precancer skin growth, 1 growth | 158 | $8,627 | $46 |
| Biopsy of related skin growth, first growth | 83 | $8,291 | $92 |
| Punch biopsy, first skin growth | 24 | $2,970 | $124 |
| New patient visit (30+ min) | 31 | $2,783 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 114 | $2,780 | $6 |
| Application of ultraviolet light to skin | 12 | $1,520 | $21 |
| Biopsy of related skin growth, each additional growth | 19 | $1,362 | $54 |
| Short return visit | 25 | $939 | $36 |
| New patient visit (15+ min) | 13 | $923 | $71 |
2018: 16 services
| Return visit (30+ min) | 176 | $18,195 | $83 |
| Short return visit (20+ min) | 166 | $11,683 | $58 |
| Biopsy of single growth of skin and/or tissue | 98 | $9,670 | $92 |
| Destruction of precancer skin growth, 1 growth | 152 | $8,792 | $47 |
| Destruction of skin growth, 1-14 growths | 62 | $7,143 | $107 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $6,037 | None |
| New patient visit (30+ min) | 41 | $3,291 | $80 |
| Destruction of precancer skin growth, 2-14 growths | 113 | $2,587 | $5 |
| New patient visit (15+ min) | 32 | $1,981 | $62 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $1,938 | $138 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,832 | $122 |
| Application of light to destroy precancer skin growth | 11 | $1,813 | $113 |
| Short return visit | 41 | $1,642 | $37 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 13 | $1,627 | $116 |
| Application of ultraviolet light to skin | 13 | $1,550 | $20 |
| Biopsy of each additional growth of skin and/or tissue | 22 | $861 | $31 |
2017: 14 services
| Return visit (30+ min) | 197 | $19,419 | $79 |
| Short return visit (20+ min) | 149 | $12,371 | $64 |
| Destruction of precancer skin growth, 1 growth | 132 | $8,703 | $48 |
| Biopsy of single growth of skin and/or tissue | 89 | $8,666 | $89 |
| Destruction of skin growth, 1-14 growths | 70 | $8,078 | $104 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 14 | $7,244 | None |
| Destruction of precancer skin growth, 2-14 growths | 101 | $3,066 | $5 |
| New patient visit (30+ min) | 33 | $2,827 | $86 |
| Application of ultraviolet light to skin | 19 | $1,995 | $21 |
| Application of light to destroy precancer skin growth | 14 | $1,886 | $111 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 11 | $1,219 | $102 |
| Short return visit | 26 | $1,137 | $42 |
| New patient visit (15+ min) | 16 | $925 | $58 |
| Biopsy of each additional growth of skin and/or tissue | 17 | $645 | $31 |
2016: 17 services
| Return visit (30+ min) | 194 | $19,916 | $79 |
| Short return visit (20+ min) | 148 | $12,157 | $63 |
| Biopsy of single growth of skin and/or tissue | 104 | $9,830 | $89 |
| Destruction of skin growth, 1-14 growths | 71 | $8,994 | $107 |
| Destruction of precancer skin growth, 1 growth | 117 | $7,413 | $49 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,926 | None |
| Application of ultraviolet light to skin | 21 | $4,760 | $21 |
| New patient visit (30+ min) | 36 | $2,895 | $80 |
| Destruction of precancer skin growth, 2-14 growths | 84 | $2,144 | $5 |
| Application of light to destroy precancer skin growth | 12 | $1,879 | $134 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $1,830 | $141 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 18 | $1,785 | $94 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,440 | $120 |
| Biopsy of each additional growth of skin and/or tissue | 26 | $1,102 | $31 |
| New patient visit (15+ min) | 17 | $997 | $59 |
| Short return visit | 20 | $915 | $42 |
| Biopsy of ear | 11 | $693 | $63 |
2015: 15 services
| Return visit (30+ min) | 180 | $19,227 | $86 |
| Short return visit (20+ min) | 129 | $10,303 | $61 |
| Biopsy of single growth of skin and/or tissue | 99 | $9,741 | $95 |
| Destruction of precancer skin growth, 1 growth | 127 | $8,337 | $53 |
| Destruction of skin growth, 1-14 growths | 60 | $7,426 | $109 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 20 | $6,438 | $307 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,484 | None |
| New patient visit (30+ min) | 44 | $3,799 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 92 | $2,378 | $6 |
| Application of light to destroy precancer skin growth | 12 | $1,887 | $145 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,877 | $125 |
| New patient visit (15+ min) | 22 | $1,420 | $65 |
| Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 13 | $1,066 | $82 |
| Biopsy of each additional growth of skin and/or tissue | 23 | $864 | $32 |
| Short return visit | 13 | $588 | $39 |
2014: 14 services
| Short return visit (20+ min) | 168 | $13,662 | $58 |
| Return visit (30+ min) | 137 | $13,368 | $84 |
| Destruction of precancer skin growth, 1 growth | 136 | $9,485 | $53 |
| Biopsy of single growth of skin and/or tissue | 91 | $8,934 | $90 |
| Destruction of skin growth, 1-14 growths | 73 | $7,867 | $102 |
| Destruction of precancer skin growth, 2-14 growths | 107 | $5,531 | $10 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $5,216 | $290 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $3,299 | None |
| New patient visit (30+ min) | 36 | $2,829 | $79 |
| New patient visit (15+ min) | 32 | $1,811 | $57 |
| Application of light to destroy precancer skin growth | 12 | $1,805 | $139 |
| Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 13 | $1,350 | $75 |
| Biopsy of each additional growth of skin and/or tissue | 31 | $1,324 | $30 |
| Short return visit | 14 | $566 | $35 |
2013: 14 services
| Return visit (30+ min) | 129 | $12,568 | $83 |
| Short return visit (20+ min) | 125 | $10,916 | $59 |
| Destruction of precancer skin growth, 1 growth | 112 | $9,136 | $61 |
| Biopsy of single growth of skin and/or tissue | 91 | $9,118 | $96 |
| Destruction of skin growth, 1-14 growths | 63 | $7,760 | $108 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $4,844 | $303 |
| Destruction of precancer skin growth, 2-14 growths | 87 | $3,292 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $2,717 | $160 |
| New patient visit (15+ min) | 43 | $2,653 | $62 |
| New patient visit (30+ min) | 31 | $2,469 | $80 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,707 | $122 |
| Biopsy of each additional growth of skin and/or tissue | 35 | $1,280 | $30 |
| Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 11 | $1,254 | $84 |
| Short return visit | 16 | $754 | $40 |
Drugs they prescribed that Part D paid
$225,596
Pharmacies billed $225,596 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 776) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
719 generic and 57 brand-name prescriptions · $225,596 in drug cost · 28 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 13 | $86,107 | $6,624 |
| Tacrolimus | 32 | $4,407 | $138 |
| Fluorouracil | 43 | $2,684 | $62 |
| Ketoconazole | 128 | $2,027 | $16 |
| Metronidazole | 31 | $1,815 | $59 |
See all 20 drugs
| Cosentyx Sensoready (2 Pens) | 13 | $86,107 | $6,624 |
| Tacrolimus | 32 | $4,407 | $138 |
| Fluorouracil | 43 | $2,684 | $62 |
| Ketoconazole | 128 | $2,027 | $16 |
| Metronidazole | 31 | $1,815 | $59 |
| Ciclopirox | 26 | $891 | $34 |
| Fluocinonide | 29 | $858 | $30 |
| Clobetasol Propionate | 35 | $734 | $21 |
| Mometasone Furoate | 36 | $712 | $20 |
| Doxycycline Hyclate | 17 | $643 | $38 |
| Econazole Nitrate | 16 | $636 | $40 |
| Betamethasone Diprop Augmented | 18 | $587 | $33 |
| Desonide | 16 | $577 | $36 |
| Triamcinolone Acetonide | 86 | $557 | $6 |
| Valacyclovir | 28 | $551 | $20 |
| Clindamycin Phosphate | 18 | $437 | $24 |
| Hydroxyzine | 13 | $378 | $29 |
| Hydrocortisone | 36 | $363 | $10 |
| Ciclopirox | 15 | $286 | $19 |
| Mupirocin | 14 | $68 | $5 |
Year by year
| 2024 | 776 | 276 | 0% (0) | 7% | $225,596 |
| 2023 | 655 | 243 | 0% (0) | 7% | $153,848 |
| 2022 | 611 | 251 | 0% (0) | 6% | $147,026 |
| 2021 | 602 | 228 | 0% (0) | 7% | $182,993 |
| 2020 | 539 | 182 | 0% (0) | 9% | $105,840 |
| 2019 | 411 | 182 | 0% (0) | 19% | $197,405 |
| 2018 | 386 | 162 | 0% (0) | 18% | $141,996 |
| 2017 | 369 | 159 | 0% (0) | 20% | $111,149 |
| 2016 | 399 | 158 | 0% (0) | None | $124,398 |
| 2015 | 364 | 153 | None | 30% | $109,273 |
| 2014 | 436 | 164 | 0% (0) | None | $127,404 |
| 2013 | 406 | 158 | 0% (0) | None | $69,230 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Humira | 11 | $83,039 | $7,549 |
| Fluorouracil | 44 | $4,339 | $99 |
| Metronidazole | 36 | $3,094 | $86 |
| Tacrolimus | 13 | $2,478 | $191 |
| Ketoconazole | 75 | $2,205 | $29 |
| Clobetasol Propionate | 36 | $1,966 | $55 |
| Calcipotriene | 12 | $1,536 | $128 |
| Fluocinonide | 37 | $1,394 | $38 |
| Valacyclovir | 37 | $1,116 | $30 |
| Mometasone Furoate | 38 | $930 | $24 |
| Betamethasone Diprop Augmented | 16 | $668 | $42 |
| Betamethasone Dipropionate | 11 | $654 | $59 |
| Desonide | 11 | $626 | $57 |
| Clindamycin Phosphate | 13 | $573 | $44 |
| Triamcinolone Acetonide | 69 | $549 | $8 |
| Ciclopirox | 17 | $498 | $29 |
| Econazole Nitrate | 14 | $390 | $28 |
| Mupirocin | 26 | $304 | $12 |
| Ciclopirox | 12 | $274 | $23 |
| Hydrocortisone | 23 | $270 | $12 |
| Doxycycline Monohydrate | 15 | $195 | $13 |
2022: 17 drugs
| Cosentyx Pen (2 Pens) | 12 | $109,104 | $9,092 |
| Fluorouracil | 60 | $5,878 | $98 |
| Metronidazole | 22 | $2,606 | $118 |
| Mometasone Furoate | 71 | $1,870 | $26 |
| Ketoconazole | 65 | $1,675 | $26 |
| Clobetasol Propionate | 29 | $1,612 | $56 |
| Fluocinonide | 30 | $1,372 | $46 |
| Clindamycin Phosphate | 21 | $1,242 | $59 |
| Betamethasone Diprop Augmented | 16 | $883 | $55 |
| Valacyclovir | 20 | $783 | $39 |
| Ciclopirox | 23 | $689 | $30 |
| Triamcinolone Acetonide | 59 | $440 | $7 |
| Doxycycline Hyclate | 11 | $436 | $40 |
| Doxycycline Monohydrate | 22 | $362 | $16 |
| Econazole Nitrate | 11 | $338 | $31 |
| Hydrocortisone | 21 | $292 | $14 |
| Mupirocin | 21 | $232 | $11 |
2021: 16 drugs
| Fluorouracil | 43 | $9,856 | $229 |
| Ketoconazole | 89 | $2,683 | $30 |
| Metronidazole | 33 | $2,465 | $75 |
| Clobetasol Propionate | 23 | $2,310 | $100 |
| Clindamycin Phosphate | 26 | $1,263 | $49 |
| Fluocinonide | 28 | $1,239 | $44 |
| Betamethasone Diprop Augmented | 12 | $1,169 | $97 |
| Desonide | 11 | $1,167 | $106 |
| Mometasone Furoate | 51 | $1,096 | $21 |
| Ciclopirox | 17 | $1,055 | $62 |
| Doxycycline Hyclate | 11 | $691 | $63 |
| Valacyclovir | 11 | $403 | $37 |
| Triamcinolone Acetonide | 37 | $397 | $11 |
| Hydrocortisone | 24 | $286 | $12 |
| Doxycycline Monohydrate | 18 | $187 | $10 |
| Mupirocin | 15 | $154 | $10 |
2020: 15 drugs
| Fluorouracil | 31 | $3,627 | $117 |
| Clobetasol Propionate | 21 | $1,976 | $94 |
| Ketoconazole | 60 | $1,806 | $30 |
| Fluocinonide | 33 | $1,619 | $49 |
| Metronidazole | 17 | $1,603 | $94 |
| Clindamycin Phosphate | 27 | $1,352 | $50 |
| Mometasone Furoate | 49 | $1,107 | $23 |
| Desonide | 13 | $998 | $77 |
| Doxycycline Hyclate | 16 | $980 | $61 |
| Ciclopirox | 16 | $658 | $41 |
| Tretinoin | 16 | $633 | $40 |
| Triamcinolone Acetonide | 38 | $289 | $8 |
| Hydrocortisone | 24 | $167 | $7 |
| Mupirocin | 13 | $97 | $7 |
| Nystatin | 11 | $93 | $8 |
2019: 12 drugs
| Enbrel Sureclick | 13 | $71,609 | $5,508 |
| Fluorouracil | 31 | $3,993 | $129 |
| Clindamycin Phosphate | 20 | $2,596 | $130 |
| Metronidazole | 23 | $2,337 | $102 |
| Ketoconazole | 40 | $1,027 | $26 |
| Mometasone Furoate | 37 | $967 | $26 |
| Fluocinonide | 18 | $880 | $49 |
| Doxycycline Hyclate | 13 | $605 | $47 |
| Ciclopirox | 14 | $577 | $41 |
| Triamcinolone Acetonide | 31 | $285 | $9 |
| Mupirocin | 12 | $135 | $11 |
| Hydrocortisone | 16 | $112 | $7 |
2018: 13 drugs
| Enbrel Sureclick | 19 | $92,516 | $4,869 |
| Tacrolimus | 11 | $3,157 | $287 |
| Clindamycin Phosphate | 17 | $2,515 | $148 |
| Fluorouracil | 19 | $2,003 | $105 |
| Metronidazole | 15 | $1,577 | $105 |
| Fluocinonide | 23 | $1,453 | $63 |
| Clobetasol Propionate | 11 | $1,203 | $109 |
| Ketoconazole | 27 | $995 | $37 |
| Mometasone Furoate | 28 | $729 | $26 |
| Triamcinolone Acetonide | 32 | $348 | $11 |
| Doxycycline Monohydrate | 11 | $171 | $16 |
| Hydrocortisone | 21 | $147 | $7 |
| Mupirocin | 13 | $105 | $8 |
2017: 13 drugs
| Enbrel Sureclick | 19 | $82,447 | $4,339 |
| Fluorouracil | 30 | $3,553 | $118 |
| Metronidazole | 24 | $2,608 | $109 |
| Desonide | 13 | $2,315 | $178 |
| Fluocinonide | 22 | $1,598 | $73 |
| Clobetasol Propionate | 16 | $1,372 | $86 |
| Ketoconazole | 32 | $1,246 | $39 |
| Mometasone Furoate | 24 | $576 | $24 |
| Valacyclovir | 13 | $293 | $23 |
| Triamcinolone Acetonide | 29 | $287 | $10 |
| Hydroxyzine | 11 | $242 | $22 |
| Mupirocin | 19 | $175 | $9 |
| Hydrocortisone | 12 | $89 | $7 |
2016: 14 drugs
| Enbrel | 23 | $88,315 | $3,840 |
| Clobetasol Propionate | 37 | $5,183 | $140 |
| Fluocinonide | 42 | $3,430 | $82 |
| Metronidazole | 20 | $2,668 | $133 |
| Desonide | 13 | $2,174 | $167 |
| Fluorouracil | 13 | $1,627 | $125 |
| Valacyclovir | 18 | $896 | $50 |
| Ketoconazole | 30 | $842 | $28 |
| Doxycycline Hyclate | 11 | $583 | $53 |
| Mometasone Furoate | 21 | $573 | $27 |
| Triamcinolone Acetonide | 26 | $289 | $11 |
| Mupirocin | 18 | $144 | $8 |
| Hydrocortisone | 11 | $90 | $8 |
| Cephalexin | 11 | $82 | $7 |
2015: 13 drugs
| Enbrel | 23 | $72,903 | $3,170 |
| Clobetasol Propionate | 35 | $5,429 | $155 |
| Desonide | 32 | $4,027 | $126 |
| Fluorouracil | 24 | $3,061 | $128 |
| Metronidazole | 18 | $2,648 | $147 |
| Fluocinonide | 22 | $1,386 | $63 |
| Doxycycline Hyclate | 11 | $964 | $88 |
| Ketoconazole | 29 | $548 | $19 |
| Hydroxyzine | 13 | $542 | $42 |
| Valacyclovir | 14 | $507 | $36 |
| Triamcinolone Acetonide | 22 | $315 | $14 |
| Mometasone Furoate | 14 | $252 | $18 |
| Mupirocin | 14 | $206 | $15 |
2014: 15 drugs
| Enbrel | 29 | $86,028 | $2,966 |
| Desonide | 39 | $5,898 | $151 |
| Fluocinolone Acetonide | 19 | $2,886 | $152 |
| Metronidazole | 19 | $2,556 | $135 |
| Clobetasol Propionate | 50 | $2,510 | $50 |
| Fluorouracil | 15 | $2,448 | $163 |
| Doxycycline Hyclate | 12 | $2,025 | $169 |
| Fluocinonide | 24 | $1,580 | $66 |
| Doxycycline Monohydrate | 18 | $1,406 | $78 |
| Ketoconazole | 36 | $640 | $18 |
| Valacyclovir | 15 | $434 | $29 |
| Doxepin | 11 | $275 | $25 |
| Mometasone Furoate | 17 | $251 | $15 |
| Triamcinolone Acetonide | 15 | $211 | $14 |
| Mupirocin | 14 | $170 | $12 |
2013: 11 drugs
| Fluorouracil | 24 | $4,705 | $196 |
| Desonide | 45 | $4,097 | $91 |
| Valacyclovir | 11 | $2,014 | $183 |
| Clindamycin Phosphate | 18 | $1,619 | $90 |
| Metronidazole | 11 | $1,411 | $128 |
| Clobetasol Propionate | 36 | $901 | $25 |
| Fluocinonide | 22 | $843 | $38 |
| Ketoconazole | 35 | $813 | $23 |
| Triamcinolone Acetonide | 27 | $423 | $16 |
| Econazole Nitrate | 14 | $339 | $24 |
| Hydroxyzine | 12 | $295 | $25 |
Money from drug and device companies
$1,121 in 2025
| 2025 | 13 | 40 | None | $1,121 |
| 2024 | 14 | 30 | None | $863 |
| 2023 | 2 | 3 | None | $209 |
| 2021 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $255 | 4 payments
|
| Janssen Biotech | Tremfya | $124 | 5 payments
|
| Galderma Laboratories L.P. | Nemluvio | $104 | 5 payments
|
| Arcutis Biotherapeutics | Zoryve | $100 | 5 payments
|
| Organon | Hadlima | $87 | 3 payments
|
| Incyte | Opzelura | $79 | 3 payments
|
See all 40 published payments
| Pfizer | Meals · 2025-12-03 | Cibinqo | $26 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Sotyktu | $32 |
| Galderma Laboratories L.P. | Meals · 2025-10-27 | Nemluvio | $26 |
| Incyte | Meals · 2025-10-21 | Opzelura | $29 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $47 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $16 |
| Lilly USA | Meals · 2025-10-13 | Taltz | $32 |
| Novartis Pharmaceuticals | Meals · 2025-10-09 | Rhapsido | $21 |
| Incyte | Meals · 2025-10-07 | Opzelura | $26 |
| Arcutis Biotherapeutics | Meals · 2025-09-16 | Zoryve | $19 |
| Janssen Biotech | Meals · 2025-09-15 | Tremfya | $14 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $27 |
| Galderma Laboratories L.P. | Meals · 2025-08-11 | None | $18 |
| Galderma Laboratories L.P. | Meals · 2025-08-11 | None | $18 |
| Janssen Biotech | Meals · 2025-08-04 | Tremfya | $23 |
| Galderma Laboratories L.P. | Meals · 2025-08-04 | Nemluvio | $23 |
| Organon | Meals · 2025-07-31 | None | $27 |
| Organon | Meals · 2025-07-22 | Vtama | $26 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $16 |
| Abbvie | Meals · 2025-07-01 | Skyrizi | $17 |
| Janssen Biotech | Meals · 2025-06-26 | Tremfya | $36 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $41 |
| Galderma Laboratories L.P. | Meals · 2025-05-19 | Nemluvio | $19 |
| Novartis Pharmaceuticals | Meals · 2025-05-08 | Cosentyx | $18 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $25 |
| Genzyme | Meals · 2025-05-01 | Dupixent | $125 |
| Regeneron Healthcare Solutions | Meals · 2025-04-17 | Dupixent | $29 |
| Arcutis Biotherapeutics | Meals · 2025-04-14 | Zoryve | $18 |
| Abbvie | Meals · 2025-04-10 | Skyrizi | $22 |
| Lilly USA | Meals · 2025-03-24 | Ebglyss | $22 |
| Organon | Meals · 2025-03-17 | Hadlima | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-03-10 | Dupixent | $32 |
| Almirall | Meals · 2025-02-11 | Klisyri | $19 |
| Incyte | Meals · 2025-02-05 | Opzelura | $24 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $42 |
| Lilly USA | Meals · 2025-01-29 | Taltz | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-28 | Cosentyx | $27 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $35 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-13 | Sotyktu | $22 |
See earlier years (2024, 2023, 2021)
2024: $863
| Regeneron Healthcare Solutions | Libtayo | $193 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $146 | 6 payments
|
| Genzyme | Dupixent | $121 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $72 | 3 payments
|
| Dermavant Sciences | Vtama | $67 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| Abbvie | Skyrizi | $35 | 1 payment
|
| Almirall | Klisyri | $33 | 2 payments
|
| Lilly USA | Ebglyss | $26 | 1 payment
|
| Incyte | Opzelura | $26 | 1 payment
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
| Pfizer | Litfulo | $25 | 1 payment
|
| Ucb | Bimzelx | $24 | 1 payment
|
| Verrica Pharmaceuticals | Ycanth | $19 | 1 payment
|
2023: $209
| Dermavant Sciences | Vtama | $136 | 1 payment
|
| Pfizer | Cibinqo | $73 | 2 payments
|
2021: $11
| STRATA Skin Sciences | Xtrac | $11 | 1 payment
|
Professional record
- NPI
- 1871543702
- Licence
- CA A69488California A69488: Current · expires 2027-06-30
- Trained
- Stanford University School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-05-11
- NPI last updated
- 2012-02-15
This is when the NPI record was last certified, not a medical board exam.